Stem cell therapy for ocular disorders

被引:22
|
作者
Levin, LA
Ritch, R
Richards, JE
Borrás, T
机构
[1] Univ Wisconsin, Sch Med, Dept Ophthalmol & Visual Sci, Madison, WI 53792 USA
[2] New York Eye & Ear Infirm, Dept Ophthalmol, New York, NY 10003 USA
[3] New York Med Coll, Dept Ophthalmol, Valhalla, NY 10595 USA
[4] Univ Michigan, WK Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI USA
[5] Univ N Carolina, Dept Ophthalmol, Chapel Hill, NC USA
关键词
D O I
10.1001/archopht.122.4.621
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Cell injury or degeneration occurs in a number of blinding diseases. Therapy has classically consisted of preventing the initial injury or increasing the resistance of cells to injury (cytoprotection). Recently, it has become possible to repopulate tissue compartments with stem cells. This article presents a current summary of ocular stem cell research and applications to disease. It is based on presentations and discussions from the July 2002 international conference "Stem Cells and Glaucoma" sponsored by the Glaucoma Foundation. This meeting, the first of its kind, brought together ophthalmologists, geneticists, immunologists, and developmental biologists working on stem cell development and applications in both human and animal models.
引用
收藏
页码:621 / 627
页数:7
相关论文
共 50 条
  • [21] Cultivated corneal epithelial stem cell transplantation in ocular surface disorders
    Koizumi, N
    Inatomi, T
    Suzuki, T
    Sotozono, C
    Kinoshita, S
    [J]. OPHTHALMOLOGY, 2001, 108 (09) : 1569 - 1574
  • [22] Stem cell therapy in ocular pathologies in the past 20 years
    Miotti, Giovanni
    Parodi, Pier Camillo
    Zeppieri, Marco
    [J]. WORLD JOURNAL OF STEM CELLS, 2021, 13 (05): : 366 - 385
  • [23] Dental stem cells: a future asset of ocular cell therapy
    Yam, Gary Hin-Fai
    Peh, Gary Swee-Lim
    Singhal, Shweta
    Goh, Bee-Tin
    Mehta, Jodhbir S.
    [J]. EXPERT REVIEWS IN MOLECULAR MEDICINE, 2015, 17 : e20
  • [24] Biomechanical Modulation Therapy: Stem Cell Therapy Without the Stem Cells for the Treatment of Severe Ocular Burns
    Gouveia, Ricardo M.
    Lepert, Guillaume
    Gupta, Suneel
    Mohan, Rajiv R.
    Paterson, Carl
    Connon, Che J.
    [J]. TOXICOLOGY LETTERS, 2020, 331 : S8 - S8
  • [25] Mesenchymal stem cell therapy for intractable neonatal disorders
    Ahn, So Yoon
    Park, Won Soon
    Sung, Se In
    Chang, Yun Sil
    [J]. PEDIATRICS AND NEONATOLOGY, 2021, 62 : S16 - S21
  • [26] A new concept of stem cell disorders and their new therapy
    Ikehara, S
    [J]. JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2003, 12 (06): : 643 - 653
  • [27] Mesenchymal stem cell therapy for degenerative inflammatory disorders
    Mueller, Ingo
    Lymperi, Stefania
    Dazzi, Francesco
    [J]. CURRENT OPINION IN ORGAN TRANSPLANTATION, 2008, 13 (06) : 639 - 644
  • [28] Stem cell therapeutics and gene therapy for neurologic disorders
    Chen, Kevin S.
    Koubek, Emily J.
    Sakowski, Stacey A.
    Feldman, Eva L.
    [J]. NEUROTHERAPEUTICS, 2024, 21 (04)
  • [29] Stem Cell Therapy for Neonatal Disorders: Prospects and Challenges
    Chang, Yun Sil
    Ahn, So Yoon
    Sung, Sein
    Park, Won Soon
    [J]. YONSEI MEDICAL JOURNAL, 2017, 58 (02) : 266 - 271
  • [30] Perspectives on stem cell gene therapy for genetic disorders
    Otsu, M.
    [J]. STATE OF THE ART PRESENTATIONS 33RD INTERNATIONAL CONGRESS OF THE INTERNATIONAL SOCIETY OF BLOOD TRANSFUSION, IN CONJUNCTION WITH THE 33RD CONGRESS OF THE KSBT AND 2014 CONGRESS OF THE KOREAN HEMATOLOGY SOCIETIES, VOL 10, NO S1, 2015, 10 (S1): : 231 - 234